How Long Do Lexapro Withdrawal Symptoms Last? Timeline, Symptoms, and Support

Guidance on the Duration of Lexapro Withdrawal Symptoms

Lexapro withdrawal symptoms often begin within a few days of a dose reduction or the final dose. Mild symptoms commonly improve within one to two weeks. Some people have symptoms for several weeks, and a smaller group reports symptoms that persist for months.

There is no exact timetable that applies to everyone. The dose, length of treatment, speed of reduction, previous withdrawal reactions, other medications, and the condition Lexapro was prescribed to treat can all affect the experience.

Our blog resource from Icarus Wellness and Recovery provides detailed guidance.

Do not stop Lexapro suddenly or change the dose without speaking with the prescribing clinician. A staged taper and regular follow-up can reduce the likelihood and severity of antidepressant withdrawal.

Quick Takeaways

• Withdrawal symptoms may appear within a few days of reducing or stopping Lexapro.
• Many mild cases improve within one to two weeks, but symptoms can last several weeks or occasionally longer.
• Dizziness, nausea, sleep disruption, anxiety, irritability, imbalance, and electric-shock sensations are among the recognized symptoms.
• Antidepressant withdrawal reflects physical dependence and adaptation to the medication. It is different from addiction.
• A taper should be based on the person’s history and response, not a fixed online schedule.
• New suicidal thoughts, loss of contact with reality, severe confusion, or an inability to remain safe require emergency evaluation.

What Is Lexapro and Why Can Stopping It Cause Symptoms?

Lexapro is the brand name for escitalopram, a selective serotonin reuptake inhibitor, or SSRI. It is approved to treat major depressive disorder and generalized anxiety disorder. The usual adult starting dose is 10 mg once daily, and the maximum labeled dose is 20 mg daily.

Escitalopram inhibits the serotonin transporter and changes serotonin signaling. With continued use, the nervous system adapts to the medication’s effects. A rapid dose reduction can leave too little time for further adaptation, which may produce antidepressant discontinuation symptoms.

The complete biology of antidepressant withdrawal is not settled. It should not be reduced to a simple claim that serotonin is suddenly “too low.” Current evidence supports a broader process of neurophysiological adjustment after the medication is reduced.

Lexapro has a mean terminal half-life of about 27 to 32 hours. Blood levels therefore fall over several days rather than disappearing immediately after the last dose. The nervous system may take longer to adjust than the medication takes to leave the bloodstream.

Is Lexapro Withdrawal the Same as Addiction?

No. Antidepressants can cause physical dependence, which means the body has adapted to the medication and may react when the dose changes. Addiction involves features such as craving, loss of control, intoxication, and compulsive use despite harm. Those features are not typical of prescribed Lexapro use.

Calling the reaction “antidepressant discontinuation syndrome” does not make the symptoms less real. “Withdrawal” and “discontinuation symptoms” are both used in clinical literature. The important distinction is between physical dependence and a substance use disorder.

How Common Is Antidepressant Withdrawal?

Published estimates vary because researchers have used different medications, treatment durations, taper methods, symptom checklists, and control groups. Older reviews often reported that half or more of people experienced symptoms. More recent controlled analyses have produced lower estimates.

A 2024 systematic review and meta-analysis estimated that about 15% of people developed one or more symptoms directly attributable to stopping an antidepressant, with severe symptoms affecting about 2% to 3%.

A 2025 meta-analysis of randomized trials found that people stopping antidepressants experienced about one additional symptom on average compared with people who stopped placebo or continued medication. Dizziness, nausea, vertigo, and nervousness showed the clearest associations.

These figures cover antidepressants as a group. They are not a precise estimate for Lexapro alone, and controlled trials may not fully represent people who have taken antidepressants for many years or previously had difficult withdrawal.

Who May Have a Higher Risk of Difficult Withdrawal?

No test can predict exactly who will develop withdrawal or how long it will last. A prescriber may use several factors when planning a taper:

• Longer treatment duration
• Higher doses within the prescribed range
• A previous difficult antidepressant taper
• Symptoms after missed doses
• A large or abrupt dose reduction
• Other medications that may affect symptoms or drug metabolism
• Active depression, anxiety, bipolar disorder, substance use, chronic pain, or another medical condition
• Limited support or major stress during the planned taper

These are planning considerations, not guarantees. Some long-term users taper without significant symptoms, while some people react to relatively small reductions.

When Do Lexapro Withdrawal Symptoms Start?

Symptoms often begin within a few days of lowering the dose, stopping the medication, or missing doses. The timing fits Lexapro’s 27 to 32-hour half-life, but it is not identical for every person.

Early symptoms may include dizziness, nausea, headache, sleep changes, irritability, anxiety, or an unfamiliar “off” feeling. Some people notice symptoms after one or two missed doses. A gradual taper may delay or reduce symptoms, and occasionally symptoms appear later.

New symptoms after a dose change should be discussed with the prescriber. Withdrawal can overlap with recurrence of depression or anxiety, side effects from another medication, infection, migraine, a vestibular problem, or another medical condition.

How Long Do Lexapro Withdrawal Symptoms Last?

According to current NICE guidance, mild antidepressant withdrawal symptoms may appear within a few days and usually resolve within one to two weeks. More difficult symptoms can last several weeks and, occasionally, several months.

That range is more defensible than assigning every person to a fixed sequence of withdrawal phases. A practical way to understand the course is:

• Early onset: Symptoms may begin during the first several days after a reduction or missed doses.
• Short-term course: Many mild reactions ease over one to two weeks.
• Longer course: Some symptoms continue for several weeks, particularly after abrupt stopping or a reduction that was too large for the individual.
• Persistent symptoms: A smaller group reports symptoms lasting for months. Persistent or worsening symptoms need clinical review rather than an assumption that every problem is withdrawal.

Recovery is not always linear. Symptoms may fluctuate as sleep, stress, illness, menstrual changes, medication adjustments, and the underlying mental health condition change. Tracking symptoms and dose changes can help a clinician identify patterns.

What Does Research Say About Protracted Withdrawal?

Some patients report persistent antidepressant withdrawal symptoms after the expected short-term period. Researchers often call this protracted antidepressant withdrawal or persistent withdrawal symptoms. There is no universally accepted diagnostic definition, and the true frequency remains uncertain.

A 2025 survey of 310 people who had attempted antidepressant discontinuation found that 20% reported symptoms lasting more than three months and 10% reported symptoms lasting more than a year. Those results should be read carefully. The study relied on self-reports from people who chose to participate, covered several antidepressants, and was not designed to estimate the rate among all Lexapro users.

An earlier online survey found a high proportion of long-lasting symptoms among respondents who had already experienced withdrawal. That sampling method is useful for describing difficult cases but cannot establish how often prolonged symptoms occur across the general population.

Some people with persistent symptoms describe alternating periods of improvement and recurrence, sometimes called “waves and windows.” This is a patient-reported pattern rather than a formal diagnostic stage. Persistent symptoms do not, by themselves, prove permanent injury. They do warrant evaluation for withdrawal, recurrence, another psychiatric condition, and medical causes.

What Are the Most Common Lexapro Withdrawal Symptoms?

Recognized antidepressant withdrawal symptoms affect several body systems. A person may experience only one or two symptoms or a broader cluster.

• Balance and sensory symptoms: dizziness, vertigo, unsteadiness, tingling, and electric-shock sensations often called brain zaps
• Digestive symptoms: nausea, abdominal discomfort, diarrhea, or reduced appetite
• Sleep symptoms: insomnia, vivid dreams, nightmares, or frequent waking
• General physical symptoms: headache, fatigue, sweating, muscle aches, and flu-like discomfort
• Emotional symptoms: irritability, anxiety, tearfulness, agitation, panic, or low mood
• Cognitive symptoms: difficulty concentrating, confusion, slowed thinking, or feeling detached

The FDA label for Lexapro lists dysphoric mood, irritability, agitation, dizziness, sensory disturbances, anxiety, confusion, headache, lethargy, emotional lability, insomnia, and hypomania among reported discontinuation events.

Do Brain Zaps Mean the Brain Is Being Damaged?

Brain zaps are a recognized sensory symptom of antidepressant withdrawal. People describe them as brief electrical or shock-like sensations, sometimes associated with eye or head movement.

Their precise biological mechanism is not fully understood. They are not currently considered evidence of structural brain damage. Report them to the prescriber, especially if they affect driving, balance, work, or sleep.

Withdrawal or a Return of Depression or Anxiety?

The distinction matters because the clinical response may differ. Timing and symptom type provide useful clues, but they do not replace an assessment.

Withdrawal often begins within days of a dose reduction and may include dizziness, electric-shock sensations, nausea, imbalance, or flu-like symptoms. Those physical and sensory symptoms are less typical of a depressive relapse.

A recurrence of depression or anxiety more often develops gradually and resembles the person’s earlier illness. Persistent loss of interest, familiar depressive thinking, sustained anxiety, and a progressive return of the previous symptom pattern may point toward recurrence.

Withdrawal and recurrence can occur together. Medication changes, sleep loss, stress, and fear about symptoms can also complicate the picture. NICE notes that relapse does not usually begin immediately after the dose is reduced. If the original medication is restarted, withdrawal symptoms may still take several days to improve.

How to Taper Lexapro More Safely and Reduce Withdrawal Risk

There is no universal Lexapro taper schedule. The prescriber and patient should agree on the speed, size of reductions, monitoring plan, and what to do if symptoms develop.

Current guidance supports several principles:

• Reduce the dose in stages rather than stopping abruptly when possible.
• Base each reduction on a proportion of the current dose, not only on a fixed number of milligrams.
• Consider smaller reductions as the dose becomes lower.
• Wait until withdrawal symptoms are resolved or tolerable before making the next reduction.
• Use a liquid formulation or another pharmacist-approved method when very small reductions are needed.
• Do not split tablets unless a prescriber or pharmacist confirms that the specific product can be divided accurately.
• Avoid skipping doses to taper unless the prescriber specifically recommends it. Fluctuating drug levels can make symptoms more likely.

A person who has taken Lexapro for a short time and has no history of withdrawal may complete a taper over weeks. Someone who has taken it for years or reacted strongly to previous reductions may need a taper lasting months or longer.

Some clinicians use a hyperbolic taper, which means reductions become proportionally smaller at lower doses. The approach reflects the nonlinear relationship between dose and serotonin-transporter occupancy. It is not a do-it-yourself formula and may require a liquid preparation or pharmacy support.

If significant symptoms appear, the prescriber may pause the taper, return to a previously tolerated dose, or resume with smaller reductions after symptoms settle. The FDA label advises that resuming the previous dose may be considered when intolerable symptoms follow a reduction, followed by a more gradual decrease.

Can Switching Antidepressants Help?

In selected cases, a prescriber may switch a patient to a longer-acting antidepressant, often fluoxetine, before completing withdrawal. This can reduce sharp fluctuations in medication levels for some people.

Switching is not appropriate for everyone. Cross-tapering and medication changes can introduce side effects, interactions, or new symptoms. The plan should account for the current dose, other medications, diagnosis, and previous responses.

Managing Symptoms During a Lexapro Taper

Supportive habits may make symptoms easier to tolerate, but they have not been proven to shorten Lexapro withdrawal.

Useful measures include:

• Keeping a consistent sleep and wake time
• Eating regular meals and drinking enough fluids
• Using gentle activity, such as walking or stretching, when tolerated
• Reducing avoidable alcohol and recreational drug use
• Recording the dose, sleep, symptoms, and major stressors
• Planning reductions during a relatively stable period when possible
• Keeping scheduled appointments with the prescriber

Breathing exercises, grounding skills, mindfulness, and progressive muscle relaxation may help with anxiety or muscle tension. They do not replace medical care for severe symptoms, and as noted above, alcohol and antidepressant use in combination should be avoided.

Ask a clinician or pharmacist before using over-the-counter pain, sleep, or anti-nausea products. Even common products may be inappropriate because of another medication, health condition, or dosing concern.

When to Contact a Clinician or Seek Emergency Care

Contact the prescriber promptly if symptoms are worsening, interfering with basic responsibilities, or continuing longer than expected.

Urgent clinical review is appropriate for severe agitation, rapidly worsening mood, suspected mania, repeated nights with very little sleep, disabling dizziness, or confusion.

Seek emergency evaluation for:

• Suicidal intent or an immediate risk of self-harm
• Loss of contact with reality
• Severe confusion or disorientation
• Inability to remain safe or care for basic needs
• A seizure, fainting, severe dehydration, or another acute medical concern

Do not assume that every new symptom is caused by Lexapro withdrawal. Severe headache, weakness on one side, chest pain, fainting, fever, persistent vomiting, or other acute physical symptoms need medical assessment.

Long-Term Care After Lexapro

Stopping medication is only one part of the treatment plan. The underlying depression, anxiety, trauma symptoms, sleep problems, or other conditions still need attention.

Cognitive behavioral therapy can help people identify unhelpful patterns, practice coping skills, and manage depression or anxiety. DBT skills, trauma-focused treatment, family work, or substance use treatment may be appropriate when those needs are present. These therapies treat the person’s diagnosed conditions and functional needs; they are not specific cures for antidepressant withdrawal.

A follow-up plan may include:

• Personal early warning signs for depression, anxiety, or mania
• A schedule for medication and therapy appointments
• Sleep, activity, and social-support goals
• A plan for responding to worsening symptoms
• Emergency contacts and clear safety steps
• Review of whether continued medication, a lower dose, or a different treatment is appropriate

Remaining on Lexapro or another medication can be the right clinical choice. Recovery does not require being medication-free.

Find Structured Mental Health Treatment Support at Icarus

Many people taper Lexapro with a prescribing clinician in an outpatient setting.

A more structured assessment may be appropriate when depression or anxiety is unstable, previous taper attempts caused significant deterioration, substance use complicates treatment, home support is limited, or the person cannot function safely at the current level of care.

Icarus Wellness & Recovery in Boise provides accredited treatment for adults with mental health and substance use disorders.

Available levels of care include residential treatment, partial hospitalization, and intensive outpatient treatment.

An assessment can help determine whether a person needs residential structure, daily PHP services, IOP support, or routine outpatient care. Please reach out today for a confidential consultation.

FAQs About Lexapro Withdrawal Duration

Can Lexapro withdrawal symptoms come and go?

Yes. Some people report fluctuating symptoms, especially during a prolonged or difficult taper. A symptom diary can help the prescriber compare changes with dose reductions, sleep, stress, illness, and the return of the original condition.

Can Lexapro withdrawal begin after a missed dose?

It can. Lexapro’s half-life is about 27 to 32 hours, and sensitive patients may notice symptoms after one or more missed doses. Do not double the next dose unless the prescriber or pharmacist instructs you to do so.

How can I know how long my withdrawal will last?

No test can predict the exact duration. Treatment length, current dose, taper speed, prior withdrawal, other medications, and individual sensitivity provide useful context, but they do not produce a reliable deadline.

Can I taper by taking Lexapro every other day?

Usually, skipping days is not the preferred method because it creates larger changes in blood levels. A prescriber may instead use smaller daily doses or a liquid formulation. Follow the plan provided for the specific prescription.

Can a longer-acting antidepressant prevent withdrawal?

A prescriber may use a longer-acting antidepressant in selected cases, but it does not guarantee a symptom-free withdrawal. Switching medications carries its own risks and requires direct clinical supervision.

How can I support someone during a Lexapro taper?

Take symptoms seriously, help with practical tasks when needed, and encourage contact with the prescribing clinician. Watch for abrupt behavioral changes, suicidal thinking, confusion, mania, or an inability to remain safe. Do not pressure the person to speed up or abandon a medically supervised taper.

References

1. American Psychiatric Association. (2010). Practice guideline for the treatment of patients with major depressive disorder (3rd ed.). American Psychiatric Association.
2. Food and Drug Administration. (2023). Lexapro (escitalopram) prescribing information.
3. Haddad, P. M., & Anderson, I. M. (2007). Recognising and managing antidepressant discontinuation symptoms. Advances in Psychiatric Treatment, 13(6), 447–457.
4. Henssler, J., et al. (2024). Incidence of antidepressant discontinuation symptoms: A systematic review and meta-analysis. The Lancet Psychiatry, 11(7), 526–535.
5. Horowitz, M. A., & Taylor, D. (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 6(6), 538–546.
6. Horowitz, M. A., et al. (2025). Antidepressants withdrawal effects and duration of use. Psychiatry Research, 347, 116403.
7. Kalfas, M., et al. (2025). Incidence and nature of antidepressant discontinuation symptoms: A systematic review and meta-analysis. JAMA Psychiatry, 82(9), 896–904.
8. National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NICE Guideline NG222). Last reviewed January 30, 2026.
9. Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R., & Krebs, W. B. (1998). Selective serotonin reuptake inhibitor discontinuation syndrome: A randomized clinical trial. Biological Psychiatry, 44(2), 77–87.
10. Royal College of Psychiatrists. (n.d.). Stopping antidepressants.
11. Warner, C. H., Bobo, W., Warner, C., Reid, S., & Rachal, J. (2006). Antidepressant discontinuation syndrome. American Family Physician, 74(3), 449–456.